Literature DB >> 15005583

Axial length, refractive error, and keratometry in patients with branch retinal vein occlusion.

M Goldstein1, I Leibovitch, D Varssano, L Rothkoff, N Feitt, A Loewenstein.   

Abstract

PURPOSE: To evaluate ocular parameters that may predispose to the development of branch retinal vein occlusion (BRVO).
METHODS: This prospective study included patients with unilateral BRVO evaluated in the authors' clinic. The mean period from the acute phase was 2.29 +/- 1.57 years (range 1-6 years). All patients underwent a complete ophthalmologic examination including subjective refraction, axial length measurements, and keratometry readings. The fellow eye served as a control in each patient. The variables of interest were compared between the affected eye and the fellow eye using the parametric t-test and the nonparametric Wilcoxon test.
RESULTS: Twenty-four consecutive patients (14 women, 10 men, mean age 62.4 years) were included in the study. The mean axial length in the affected eye was significantly shorter compared to the mean fellow eye length. No difference was found between the two eyes in mean subjective refraction or mean keratometry readings.
CONCLUSIONS: The authors found that eyes with BRVO have a shorter axial length compared to the fellow eye in the same patient.

Entities:  

Mesh:

Year:  2004        PMID: 15005583     DOI: 10.1177/112067210401400106

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

1.  Nanophthalmos and hemiretinal vein occlusion: A case report.

Authors:  Ahmad A Albar; Sawsan R Nowilaty; Nicola G Ghazi
Journal:  Saudi J Ophthalmol       Date:  2014-11-27

2.  Association between retinal vein occlusion, axial length and vitreous chamber depth measured by optical low coherence reflectometry.

Authors:  Andrea Szigeti; Miklós Schneider; Mónika Ecsedy; Zoltán Zsolt Nagy; Zsuzsanna Récsán
Journal:  BMC Ophthalmol       Date:  2015-04-30       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.